Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
Introduction Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
B Godman, M Haque, S Kumar… - Current Medical …, 2021 - pureportal.strath.ac.uk
Introduction: Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
B Godman, M Haque, S Kumar… - Current Medical …, 2021 - strathprints.strath.ac.uk
Introduction: Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
B Godman, M Haque, S Kumar… - Current medical …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
B Godman, M Haque, S Kumar, S Islam… - Current Medical …, 2021 - purerims.smu.ac.za
Introduction: Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
[PDF][PDF] Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future Short title …
J Charan, F Akter, A Kurdi, E Allocati, MA Bakar… - academia.edu
Introduction: Prevalence rates for diabetes mellitus continue to rise, which coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future.
B Godman, M Haque, S Kumar, S Islam… - Current Medical …, 2021 - europepmc.org
Results Typically, there was increasing use of long-acting insulin analogues among the
selected Asian countries. This was especially the case enhanced by biosimilars in …
selected Asian countries. This was especially the case enhanced by biosimilars in …
Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
B Godman, M Haque, S Kumar, S Islam… - Current Medical …, 2021 - pure.ewha.ac.kr
Introduction: Prevalence rates for diabetes mellitus continue to rise, which, coupled with
increasing costs of complications, has appreciably increased expenditure in recent years …
increasing costs of complications, has appreciably increased expenditure in recent years …